Omada Health (OMDA)
Runs between-visit care for cardiometabolic, MSK, GLP-1, and behavioral-health needs.
Something off on this page? Send us feedback.
Sells access to virtual chronic-care programs through employers, health plans, PBMs, and health systems. Revenue is tied mainly to services for enrolled members, with one reportable segment spanning cardiometabolic care, GLP-1 support, MSK care, behavioral-health support, and connected-device enablement.
Runs a B2B virtual-care platform for chronic conditions, with health plans, self-insured employers, PBMs, and health systems offering programs to covered lives. Core programs cover cardiometabolic care, GLP-1 support, musculoskeletal care, and behavioral-health support, wrapped with software, care teams, behavior-change protocols, and connected devices.
Started in diabetes prevention and broadened into multi-condition between-visit care, including MSK care added through the Physera acquisition. The business is concentrated in the US and reports one operating segment for all virtual care program offerings.
Execution depends on customer and channel acceptance, member enrollment and engagement, outcomes evidence, billing model durability, healthcare regulation, and competition from digital-health and broader healthcare providers.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 11, 2026 | Barclays | Reiterate | Rating: —Target: $25 | Target: $27 |
| Aug 12, 2026 | Robert W. Baird | Target | Target: $24 | Target: $25 |
| Aug 10, 2026 | BTIG | Reiterate | Rating: —Target: $30 | Target: $35 |
| Aug 7, 2026 | BMO Capital | Reiterate | Rating: —Target: — | Target: $24 |
| Aug 3, 2026 | Barclays | Reiterate | Rating: —Target: $22 | Target: $25 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $221.7M · Total debt $0 · Total assets $328.2M · Shareholders' equity $252.7M
- Revenue
- $87.8M
- Operating income
- $3.5M
- Net income
- $5.3M
No dividends on record.
| Institutions | ≈ 88.20% | 52.43M shares | |
|---|---|---|---|
| 160 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 3.64% | 2.17M shares | |
| 11 holders · as of Sep 14, 2026 | |||
| Strategic holders | 14.55% | 8.65M shares | |
| 2 holders · as of Jun 23, 2026 | |||
| Adds to | 106.39% | ||
59.45M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 106.39%; nothing is left for Other.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Revelation Alpine, LLC1Strategic10 percent owner | 8.76% | 5.21M | filed Jun 9, 2025 |
Revelation Capital Management, LLCInstitution | 8.17% | 4.86M | as of Jun 30, 2026 |
Divisadero Street Capital Management, LPInstitution | 6.39% | 3.80M | as of Jun 30, 2026 |
American Century Companies IncInstitution | 6.19% | 3.68M | as of Jun 30, 2026 |
The Cigna GroupStrategic | 5.79% | 3.44M | filed Jun 23, 2026 |
- Reported at 0.90% on Aug 12, 2025, under the 5% line, so no further filing is required.
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 10, 2026 | Steven L. Cook | officer: Chief Financial Officer | −6,800 | $21.86 |
| Sep 10, 2026 | Sean P. Duffy | director, officer: Chief Executive Officer | −14,960 | $21.87 |
| Sep 10, 2026 | Wei-Li Shao | officer: President | −4,036 | $21.85 |
| Sep 9, 2026 | Craig Gracey | officer: Chief Accounting Officer | −644 | $21.73 |
| Sep 1, 2026 | Sean P. Duffy | director, officer: Chief Executive Officer | −21,572 | $23.62 |
- Teladoc Health
Livongo-led chronic care overlap across cardiometabolic programs
- Hinge Health
Focused digital MSK rival with employer, plan, and PBM reach
- DarioHealth
Multi-condition digital-health suite across metabolic, MSK, and behavioral care
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Omada Health | $20.47 | −4.23% | $1.27B | 339.2 | 68.8 | 4.1 | +43.1% |
| Teladoc Health | $6.21 | −2.28% | $1.15B | — | — | 0.5 | −4.0% |
| Hinge Health | $91.94 | −2.35% | $7.29B | 73.2 | 34.9 | 10.1 | +53.0% |
| DarioHealth | $6.80 | −1.31% | $50.4M | 10.0 | — | 2.4 | −3.6% |
| Median | 41.6 | 34.9 | 2.4 | −3.6% |